[{"Assets_0_Q1_USD":"59854000000.0","CIK":"818686","CommonStockSharesConverted_0_Q1_shares":"1198000000.0","Country":"Israel","EarningsPerShareBasic_1_Q1_USD":"-0.1","EarningsPerShareDiluted_1_Q1_USD":"-0.1","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"11303387401.0","MinorityInterest_0_Q1_USD":"1089000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"112000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"-105000000.0","NetIncomeLoss_1_Q1_USD":"-105000000.0","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","ProfitLoss_1_Q1_USD":"-97000000.0","RevenuesConverted_1_Q1_USD":"4295000000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"15821000000.0","StockholdersEquity_0_Q1_USD":"14732000000.0","Ticker":"TEVA","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"1090000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"1090000000.0","filed":"20190502","footnote":null,"form":"10-Q","fp":"Q1","fy":"2019.0","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","period":"20190331","qtrs":"0","uom":"USD"}]